Understand the source comparison
O-304 vs. Similar Peptides: Side Effect Comparison
O-304 is often compared with other research peptides like BPC-157 and TB-500, which are also not FDA-approved. While BPC-157 is known for its potential in tissue repair with reported side effects like dizziness and fatigue, TB-500 is noted for possible injecti
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- O-304 is often compared with other research peptides like BPC-157 and TB-500, which are also not FDA-approved. While BPC-157 is known for its potential in tissue repair with reported side effects like dizziness and fatigue, TB-500 is noted for possible injection site reactions. O-304's side effect profile remains less defined due to its research status.